tirzepatide approval FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide — Amplify Aesthetics

Methods: This multicenter retrospective cohort study evaluated adult patients with T2DM and ESRD, including those receiving maintenance hemodialysis, who were prescribed injectable semaglutide between January 2016 and July 2025 at tertiary care centers in Saudi Arabia

Editor's note: This blog was revised to include updated information on May 29, 2025

10.2337/dci18-0033 2

It is best for longevity-focused, self-directed patients who are comfortable with medium support levels and want GLP-1 therapy as part of a broader anti-aging protocol

Laura Wang: Absolutely

Renal Elimination Primarily excreted unchanged by the kidneys